Isomorphic Labs · 201–500 people · Series A
Research Lead (Formulation Sciences), London
- London
- Hybrid · 3 days in office
- Lead
Lead (pre)-formulation strategy for small molecules across drug discovery and preclinical development, designing technologies such as solid dispersions and co-crystals to improve solubility, stability and manufacturability. Interpret stability studies using ICH and ASAP methods, author regulatory submissions, and work with drug design, preclinical and CMC teams while managing external CRO resources.
ICH · ASAP · FDA